$TLRY

Tilray Brands (TLRY) reported that its Global General Counsel exercised 160,304 performance-based restricted stock units (PSUs) into common shares. The Compensation Committee certified 96.4% achievement of the 2023 EBITDA target, leading to a 92.8% payout of the PSU awards. 84,962 shares were withheld to cover tax obligations at $4.88 per share.

Tilray Brands (TLRY) reported that CEO Irwin D. Simon's 1.21M performance-based restricted stock units converted into shares on August 26, 2026. 642,450 shares were withheld for taxes at $4.88 per share. The Compensation Committee certified 96.4% of the performance target, leading to a 92.8% payout of the 2023 EBITDA PSU awards.

Tilray Brands (TLRY) CFO Carl A. Merton exercised 168,452 performance-based restricted stock units, converting them into common shares. The Compensation Committee certified 96.4% achievement of the performance target, resulting in a 92.8% payout. 92,649 shares were withheld at $4.88 per share for tax obligations.

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

Shepherd Neame reopened a refurbished pub in London. Carlsberg reported 2.6% revenue growth to $7.3bn for H1 2026. LTC launched a Wellbeing Platform for hospitality professionals. Tilray Brands will stop brewing at Terrapin Beer Co's Georgia facility. Amber Taverns reported 3.7% like-for-like sales growth and appointed a new CEO. Valiant Pub Group acquired The Milton Arms from True North Brew Co. Greene King is reportedly selling 65 pubs. Punch acquired two pubs in the South West.

Tilray Brands, Inc. (TLRY) expanded its global cannabis cultivation capacity to 275 metric tonnes annually, up from 210, to meet international medical cannabis demand. The increase is driven by expanded output at its Quebec and Portugal facilities. CEO Irwin D. Simon highlighted the company's global leadership and long-term growth strategy. Tilray aims to strengthen its supply infrastructure and serve key medical cannabis markets.

Tilray (TLRY) rose 6% to $4.75, Canopy Growth (CGC) 3% to $1.02, and Aurora Cannabis (ACB) 4% to $3.80, driven by Treasury buybacks lowering yields. Tilray is still down 47% YTD, despite diversification into non-cannabis segments. The cannabis sector's performance varies, with ETFs like MJ and MSOS showing mixed results.

Tilray Brands launched a limited-edition 'Park IPA' for BrewDog's Punk IPA in the UK, part of a summer marketing campaign. 20,000 cans will be sold in London via Deliveroo and select retailers. Tilray cited research showing 70% of young Londoners drink alcohol in parks during summer. The campaign supports the broader summer drinking season. Tilray acquired BrewDog in March, including global brand rights and UK operations.

Tilray Medical, a division of Tilray Brands (Nasdaq: TLRY; TSX: TLRY), said it welcomes Germany’s KBV and GKV-Spitzenverband guidance on prescribing standardized full-spectrum medical cannabis extracts. Tilray noted legal and regulatory issues remain and called for legislative clarity to support physician confidence, patient access, and reimbursement stability. It cited 45% Germany oil market share.